Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

To evaluate patterns of rrHL after contemporary first-line treatment we studied 409 patients with first rrHL (HD13: n = 87, HD14: n = 118, HD15: n = 188, HDR3i: n = 51) at a median age of 37.4 years (18.4–76.8) from the GHSG database. Time to first relapse was ≤12 months in 49% and stage III/IV rrHL...

Descripción completa

Detalles Bibliográficos
Autores principales: Bröckelmann, Paul J., Müller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas, von Tresckow, Bastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885415/
https://www.ncbi.nlm.nih.gov/pubmed/34628472
http://dx.doi.org/10.1038/s41375-021-01442-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885415/
https://www.ncbi.nlm.nih.gov/pubmed/34628472
http://dx.doi.org/10.1038/s41375-021-01442-8

Ejemplares similares